NCT04168879View on ClinicalTrials.gov

Sphenopalatine Ganglion Block for Nasal Surery

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

December 10, 2023

Study Completion Date

December 10, 2023

Conditions
Emergence Agitation
Interventions
DRUG

Bupivacaine 0.5% Preservative-Free Injectable Solution

1.5 ml of Bupivacaine 0.5% Preservative-Free Injectable Solution used to block the sphenopalatine ganglion by ultrasound guided suprazygomatic approach

DRUG

normal saline

1.5 ml of normal saline is delivered to the sphenopalatine ganglion by ultrasound guided suprazygomatic approach

Trial Locations (1)

71111

Faculty of Medicine, Asyut

All Listed Sponsors
collaborator

saeid metwaly abouelyazid elsawy

UNKNOWN

lead

Assiut University

OTHER

NCT04168879 - Sphenopalatine Ganglion Block for Nasal Surery | Biotech Hunter | Biotech Hunter